SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : QLT PhotoTherapeutics (QLTI)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: tuck who wrote (1273)5/12/2003 4:39:02 PM
From: Ian@SI  Read Replies (1) of 1321
 
It could be viewed as positive: QLT won't be spending as much trying to get T approved!

At this point, it's too early to form any conclusions. T may have worked so well that previous safe dosages for cancer treatment drugs have to be substantially reduced. It's conceivable that cancer patients will be treated with T and a much lower dose of the toxic injections that attack the cancer.

In any case, QLT the stock remains unloved by the market.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News